July 2018 FDA Recall Fluocinolone Acetonide Topical by Teva Pharmaceuticals Usa
D-0909-2018 - Failed Impurities and Degradation Specifications and Subpotent Drug
This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on July 5, 2018 for the product Fluocinolone Acetonide Topical. The FDA reported the reason for recall as failed impurities and degradation specifications and subpotent drug. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0909-2018
Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.
07-05-2018
07-18-2018
27,803 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Teva Pharmaceuticals USA
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the USA and Puerto Rico
04-03-2019
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle, Rx Only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108 USA; Distributed by: Actavis Pharmac, Inc., Parsippany, NJ 07054 USA, NDC 0591-2990-60.
Batch or Lot Expiration Information
Lot# s: 1164898, EXP 10/18; 1164904, 1164909, EXP 11/18; 1211396, EXP 07/19; 1230808, 1231127, EXP 01/20